John C Hart Selected Research

2- ((2'- amino)propionyl)aminobicyclo(3.1.0)hexane- 2,6- dicarboxylic acid

2/2006

Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John C Hart Research Topics

Disease

1	Rupture 12/2018
1	Miosis 10/2014
1	Mydriasis 10/2014
1	Anthrax 11/2007
1	Psychotic Disorders (Schizoaffective Disorder) 02/2006
1	Mental Disorders (Mental Disorder) 02/2006
1	Anxiety Disorders (Anxiety Disorder) 12/2005

Drug/Important Bio-Agent (IBA)

1	Capsules (Microcapsules)IBA 12/2018
1	SiliconesIBA 12/2018
1	MetalsIBA 12/2018
1	AticaprantIBA 10/2014
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2014
1	Morphine (MS Contin)FDA LinkGeneric 10/2014
1	Naloxone (Narcan)FDA LinkGeneric 10/2014
1	Naltrexone (ReVia)FDA LinkGeneric 10/2014
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2014
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2014
1	ZincIBA 11/2007
1	AntigensIBA 11/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2007
1	2- ((2'- amino)propionyl)aminobicyclo(3.1.0)hexane- 2,6- dicarboxylic acidIBA 02/2006
1	AcidsIBA 02/2006
1	Glutamic Acid (Glutamate)FDA Link 02/2006
1	eglumetadIBA 02/2006
1	ProdrugsIBA 02/2006
1	LY 379268IBA 02/2006
1	HexanesIBA 02/2006
1	Pharmaceutical PreparationsIBA 02/2006

Therapy/Procedure

1	Transjugular Intrahepatic Portasystemic Shunt 12/2018
1	Induced Hyperthermia (Thermotherapy) 12/2005